AMBIT BIOSCIENCES CORP
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | |
|---|---|---|
| Revenue | — | — |
| Operating income | −$7.0M | −$23.2M |
| Net income | −$11.2M | −$26.6M |
| Total assets | $73.9M | $20.0M |
| Total liabilities | — | — |
| Equity | $57.6M | −$198.2M |
| EPS (diluted) | — | — |
| Shares out. | 17.9M | 3,990 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- —
- Net margin
- —
- Return on equity
- −19.4%
- Return on assets
- −15.1%
- Return on capital (ROCE)
- −12.2%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $3.21
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Accruals / assets
- 21.8%high accruals
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 0 good- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 17, 2014
- Entered a material agreementSep 29, 2014
- Amended charter or bylawsSep 4, 2014
- Results of operationsAug 12, 2014
- Director / officer changeJun 4, 2014
- Director / officer change · Shareholder voteMay 19, 2014
- Results of operationsMay 6, 2014
- Results of operationsMar 20, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4Dec 22, 2014
- SC 13G/ADec 10, 2014
- 15-12BNov 25, 2014
- EFFECTNov 21, 2014
- POS AMNov 20, 2014
- S-8 POSNov 20, 2014
- S-8 POSNov 20, 2014
- SC 13D/AAMENDMENT NO. 1Nov 19, 2014
- 8-KFORM 8-KNov 17, 2014
- 4PRIMARY DOCUMENTNov 13, 2014
- SC 14D9/AAMENDMENT NO.3 TO SC 14D9Nov 13, 2014
- 4PRIMARY DOCUMENTNov 12, 2014
- 4PRIMARY DOCUMENTNov 12, 2014
- 4PRIMARY DOCUMENTNov 12, 2014
- SC TO-T/ANov 12, 2014
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.